WO2001012776A3 - 18 human secreted proteins - Google Patents

18 human secreted proteins Download PDF

Info

Publication number
WO2001012776A3
WO2001012776A3 PCT/US2000/022350 US0022350W WO0112776A3 WO 2001012776 A3 WO2001012776 A3 WO 2001012776A3 US 0022350 W US0022350 W US 0022350W WO 0112776 A3 WO0112776 A3 WO 0112776A3
Authority
WO
WIPO (PCT)
Prior art keywords
secreted proteins
human secreted
proteins
novel human
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/022350
Other languages
French (fr)
Other versions
WO2001012776A2 (en
Inventor
Yanggu Shi
Paul E Young
Reinhard Ebner
Daniel R Soppet
Steven M Ruben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Priority to AU70591/00A priority Critical patent/AU7059100A/en
Priority to EP00959237A priority patent/EP1212342A4/en
Priority to JP2001517661A priority patent/JP2003507030A/en
Priority to CA002385475A priority patent/CA2385475A1/en
Priority to US09/768,826 priority patent/US20020012966A1/en
Publication of WO2001012776A2 publication Critical patent/WO2001012776A2/en
Publication of WO2001012776A3 publication Critical patent/WO2001012776A3/en
Anticipated expiration legal-status Critical
Priority to US10/874,484 priority patent/US7381800B2/en
Priority to US11/962,255 priority patent/US20090042792A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.
PCT/US2000/022350 1999-08-16 2000-08-15 18 human secreted proteins Ceased WO2001012776A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU70591/00A AU7059100A (en) 1999-08-16 2000-08-15 18 human secreted proteins
EP00959237A EP1212342A4 (en) 1999-08-16 2000-08-15 18 HUMAN SECRETED PROTEINS
JP2001517661A JP2003507030A (en) 1999-08-16 2000-08-15 18 human secreted proteins
CA002385475A CA2385475A1 (en) 1999-08-16 2000-08-15 18 human secreted proteins
US09/768,826 US20020012966A1 (en) 1999-08-16 2001-01-25 18 Human secreted proteins
US10/874,484 US7381800B2 (en) 1999-08-16 2004-06-24 Antibodies to HBIMF63 polypeptide
US11/962,255 US20090042792A1 (en) 1999-08-16 2007-12-21 18 human secreted proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14875999P 1999-08-16 1999-08-16
US60/148,759 1999-08-16

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/768,826 Continuation-In-Part US20020012966A1 (en) 1999-08-16 2001-01-25 18 Human secreted proteins

Publications (2)

Publication Number Publication Date
WO2001012776A2 WO2001012776A2 (en) 2001-02-22
WO2001012776A3 true WO2001012776A3 (en) 2001-08-30

Family

ID=22527234

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/022350 Ceased WO2001012776A2 (en) 1999-08-16 2000-08-15 18 human secreted proteins

Country Status (6)

Country Link
US (3) US20020012966A1 (en)
EP (1) EP1212342A4 (en)
JP (1) JP2003507030A (en)
AU (1) AU7059100A (en)
CA (1) CA2385475A1 (en)
WO (1) WO2001012776A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6893844B1 (en) * 1998-09-22 2005-05-17 Long Yu DNA encoding a new human hepatoma derived growth factor and producing method thereof
US20050107592A1 (en) * 2000-04-05 2005-05-19 Matthias Grell Lipid binding protein 1
AU2001296645A1 (en) 2000-10-06 2002-04-15 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding dna and rna
US9708358B2 (en) 2000-10-06 2017-07-18 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
US7227007B2 (en) * 2000-12-28 2007-06-05 Asahi Kasei Pharma Corporation NF-κB activating gene
JP4344519B2 (en) * 2000-12-28 2009-10-14 旭化成ファーマ株式会社 NF-κB activating gene
US20040229849A1 (en) * 2002-09-24 2004-11-18 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20060281672A1 (en) * 2002-12-06 2006-12-14 Hart Derek N J Dec-205 (ly 75)/dcl-1 intergenic splice variants associated with hodgkin's disease, and uses thereof
US20090130109A1 (en) * 2002-12-06 2009-05-21 Derek Nigel John Hart DCL-1 and uses thereof
EP2436778A3 (en) * 2004-03-03 2012-07-11 The Trustees of Columbia University in the City of New York Photocleavable fluorescent nucleotides for DNA sequencing on chip constructed by site-specific coupling chemistry
WO2006024169A1 (en) * 2004-09-01 2006-03-09 Hemax Genome Inc. Genes of the pseudoautosomal region 1 and their use in the diagnosis, treatment and prevention of autoimmune diseases
US9169510B2 (en) * 2005-06-21 2015-10-27 The Trustees Of Columbia University In The City Of New York Pyrosequencing methods and related compositions
WO2007062105A2 (en) * 2005-11-21 2007-05-31 The Trustees Of Columbia University In The City Of New York Multiplex digital immuno-sensing using a library of photocleavable mass tags
GB2457402B (en) 2006-12-01 2011-10-19 Univ Columbia Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators
WO2009035673A1 (en) * 2007-09-12 2009-03-19 Trustees Of Columbia University In The City Of Newyork Compositions and methods for treating macular degeneration
DK2725107T3 (en) 2007-10-19 2019-01-02 Univ Columbia DNA Sequencing with Non-Fluorescent Nucleotide Reversible Terminators and ddNTPs Modified by Split Label and Nucleic Acid comprising Inosine with Reversible Terminators
WO2009051807A1 (en) 2007-10-19 2009-04-23 The Trustees Of Columbia University In The City Of New York Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequencing by synthesis
WO2014144883A1 (en) 2013-03-15 2014-09-18 The Trustees Of Columbia University In The City Of New York Raman cluster tagged molecules for biological imaging
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
CN116875542B (en) * 2023-09-08 2023-11-10 苏州依科赛生物科技股份有限公司 Mesenchymal stem cell culture enhancer and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 17 October 1996 (1996-10-17), HILLIER ET AL.: "Source: clone_lib= Soares_fetal_heart_NbHH19W", XP002954020, accession no. EST Database accession no. W76255 *
DATABASE GENBANK [online] 4 September 1998 (1998-09-04), WOESSNER ET AL.: "Human full length insert cDNA clone ZD66F06; source: clone_lib=soares_fetal_heart_NbHH19W", XP002954019, accession no. GenEmbl Database accession no. AF088057 *
See also references of EP1212342A4 *

Also Published As

Publication number Publication date
CA2385475A1 (en) 2001-02-22
US7381800B2 (en) 2008-06-03
US20090042792A1 (en) 2009-02-12
US20020012966A1 (en) 2002-01-31
EP1212342A2 (en) 2002-06-12
JP2003507030A (en) 2003-02-25
AU7059100A (en) 2001-03-13
US20040235113A1 (en) 2004-11-25
WO2001012776A2 (en) 2001-02-22
EP1212342A4 (en) 2003-04-02

Similar Documents

Publication Publication Date Title
WO1998039446A3 (en) 70 human secreted proteins
WO1998039448A3 (en) 186 human secreted proteins
WO1998040483A3 (en) 28 human secreted proteins
WO1998031800A3 (en) Human proteins
EP1053245A4 (en) 45 HUMAN SECRETED PROTEINS
WO2001036432A3 (en) 18 human secreted proteins
WO2001032910A3 (en) 27 human secreted proteins
WO1998045712A3 (en) 20 human secreted proteins
CY1111950T1 (en) 32 HUMAN EXTRACTED PROTEINS
WO2001034768A3 (en) 15 human secreted proteins
WO2001012776A3 (en) 18 human secreted proteins
WO2000077026A8 (en) 49 human secreted proteins
WO2000017222A8 (en) 31 human secreted proteins
WO2000052136A3 (en) Human glycosylation enzymes
WO2000063230A3 (en) 49 human secreted proteins
WO2001062891A3 (en) 207 human secreted proteins
WO2000073323A3 (en) Adam polynucleotides and polypeptides
EP1042342A4 (en) 53 HUMAN SECRETED PROTEINS
WO2000058339A3 (en) 50 human secreted proteins
WO2001012775A8 (en) 25 human secreted proteins
WO2000061624A8 (en) 48 human secreted proteins
WO2000043495A3 (en) 33 human secreted proteins
WO2000061596A8 (en) 50 human secreted proteins
WO2003052377A9 (en) 41 human secreted proteins
WO2001034769A3 (en) 24 human secreted proteins

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 09768826

Country of ref document: US

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2385475

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000959237

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000959237

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000959237

Country of ref document: EP